What is the recommendation for the use of prasugrel in patients with non-ST elevation acute coronary syndromes (NSTE-ACS)?
On the basis of the TRITON study design and results of TRILOGY ACS and ACCOAST, prasugrel is not recommended for upfront therapy in patients with NSTE-ACS. The use of prasugrel in patients undergoing PCI is addressed in Section 5.